Stockreport

Generex Announces Acquisition of 100% of Hema Diagnostic Systems, Debt Restructuring & Warrant Deal

GENEREX BIOTECHNOLOGY  (GNBT) 
US:NASDAQ Investor Relations: generex.com/investor
PDF Secures remaining 49% of HDS for $1.00 Debt restructuring erases $13,431,705.66 note Pays off $624,403.64 note with 3 [Read more]